Funder: Melanoma Research Alliance
Due Dates (Anticipated): November 2026 (Full proposal submission deadline for Pilot Awards, projected)
Funding Amounts: Typical award size not specified in current guidance; MRA plans to support at least $11.5 million in new funding across all awards in the 2025–2026 cycle.
Summary: Funds high-risk, high-reward translational melanoma research projects to establish proof-of-concept for potentially transformative ideas.